Therapeutic effect of trimetazon and other pyrazolidins in phlebic disorders
Krcilek, A.; Smejkal, V.
Sbornik Lekarsky 73(4): 105-109
1971
ISSN/ISBN: 0036-5327 PMID: 5552778 Document Number: 31011
Document emailed within 1 workday
Related Documents
Bezuur, N.J.; Habets, L.L.; Hansson, T.L. 1988: The effect of therapeutic laser treatment in patients with craniomandibular disorders Journal of Craniomandibular Disorders 2(2): 83-86Bian, J-Ling.; Zhang, C-Hong.; Li, J-Bo.; Zhang, Y.; Ding, S-Qiang.; He, J.; Shi, X-Min. 2005: Observation on therapeutic effect of activating brain function to cause resuscitation needling method on deglutition disorders after stroke Zhongguo Zhen Jiu 25(5): 307-308
Queisnerová, M.; Nĕmecek, O. 1971: Absorption, distribution and excretion rate in diphenyldioxypyrazolidine drugs -14 C-kebuzon and 14 C- trimetazon- in rats Ceskoslovenska Farmacie 20(2): 55-59
Neznamov, G.G.; Morozov, I.S.; Barchukov, V.G.; Teleshova, E.S.; Siuniakov, S.A.; Zhirov, E.N.; Tkachev, A.E.; Belyĭ, I.N.; Kolotilinskaia, N.V.; Safarova, T.P.; Barannikov, A.S.; Chernyĭ, A.V.; Shestopalov, S.S. 1997: The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level Eksperimental'naia i Klinicheskaia Farmakologiia 60(4): 17-21
Fareed, J.; Bick, R.L.; Squillaci, G.; Walenga, J.M.; Bermes, E.W. 1983: Molecular markers of hemostatic disorders: implications in the diagnosis and therapeutic management of thrombotic and bleeding disorders Clinical Chemistry 29(9): 1641-1658
Lôo, H.; Daléry, J.; Macher, J.P.; Payen, A. 2003: Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders L'Encephale 29(2): 165-171
Sugiyama, H.; Horiuchi, A.; Hasegawa, H.; Kitani, T.; Tagawa, S.; Masaoka, T.; Tejima, H.; Yonezawa, T.; Take, H.; Kawagoe, H. 1992: Therapeutic effects of meropenem against severe infections in patients with hematopoietic disorders. Hanshin Study Group of Hematopoietic Disorders and Infection Japanese Journal of Antibiotics 45(6): 687-696
Ulashchik, V.S. 1998: The effect of physical factors on the action of other therapeutic means (the problem of therapeutic interference) Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 46-49
Mathé, J.F.; Cler, J.M.; Venisse, J.L. 1978: Therapeutic use of tiapride in movement disorders La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 54(13-16): 517-520
Kes, P. 1997: Therapeutic plasma exchange in neurologic disorders Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 51(4-5): 225-228
Chimenti, S.; Faina, P. 1978: Therapeutic activity of aminaphthone in purpuric disorders La Clinica Terapeutica 84(5): 501-508
Nissen, G. 1978: Therapeutic possibilities in child behavior disorders Die Medizinische Welt 29(35): 1358-1361
Swedenborg, J. 1980: Questioning a therapeutic proposal for bleeding disorders Lakartidningen 77(47): 4371
Klatzo, I.; Smijalek, M.; Hervonen, G.; Steinwall, O.; Spatz, M. 1980: Postischemic disorders and the therapeutic measures in brain ischemia Anesteziologiia i Reanimatologiia 5: 29-33
Jani, L.; Morscher, E. 1977: Therapeutic principles in post-traumatic growth disorders Zeitschrift für Orthopadie und ihre Grenzgebiete 115(4): 586-592
Tsuji, N.; Takahashi, F. 2007: Therapeutic agents for disorders of bone and calcium metabolism: ED-71 Clinical Calcium 17(1): 72-79
Schmidt, R.M.; Jeschke, B. 1973: Pathogenetic and therapeutic considerations in central hearing disorders Das Deutsche Gesundheitswesen 28(8): 363-365
Koide, S.S. 1998: Mifepristone. Auxiliary therapeutic use in cancer and related disorders Journal of Reproductive Medicine 43(7): 551-560
Naveau, S.; Mory, B.; Poynard, T.; Chaput, J.C. 1990: Randomized therapeutic trials in intestinal functional disorders Gastroenterologie Clinique et Biologique 14(5): 65c-73c
Kockott, G. 1989: Diagnostic and therapeutic possibilities in psychological disorders as a cause of impotence Der Urologe. Ausg. a 28(5): 248-252